FDA approves AIM Vaccine's mRNA RSV vaccine for U.S. clinical trials
FDA approves AIM Vaccine's mRNA RSV vaccine for U.S. clinical trials
News
-
CPIVC NEWS
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
learn more »
CPIVC 2025-05-24
-
CPIVC NEWS
China launches clinical trial of domestic tuberculosis vaccine
China launches clinical trial of domestic tuberculosis vaccine
learn more »
CPIVC 2025-05-23
-
CPIVC NEWS
China NMPA approves SIBP, RongCan's herpes zoster mRNA vaccine for clinical trials
China NMPA approves SIBP, RongCan's herpes zoster mRNA vaccine for clinical trials
learn more »
CPIVC 2025-05-23
-
CPIVC NEWS
AIM Vaccine's Serum-Free Iterative Rabies Vaccine Has Received Production License and Will Submit for Market Registration
AIM Vaccine's Serum-Free Iterative Rabies Vaccine Has Received Production License and Will Submit for Market Registration
learn more »
CPIVC 2025-05-22
-
CPIVC NEWS
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
learn more »
CPIVC 2025-05-22
-
CPIVC English Website was Officially Launched on Mar 10, 2025 -Your Gateway to Global Vaccine Cooperation
CPIVC English Website was Officially Launched on Mar 10, 2025 -Your Gateway to Global Vaccine Cooperation
learn more »
CPIVC 2025-03-28
Scan the QR code to follow
us on WeChat
京公网安备 11010802041931号 © 2024 cpivc.com